NEWPORT BEACH, CA , Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it is adding new strains to its current Amster-Can branded lineup of OG Kush, Gorilla Glue, and Blue Dream. The company CEO, Darren Cherry, says they the company just formed a new partnership with Master Win, a northern California master grower, who works with a medical cannabis research and cultivation organization.
“We package a number of different strains for different partners and clients,” Advantis CEO Darren Cherry, said. “We only have the three strains we package with Natural Elements that we put our branded Amster-Can label on. We expect this partnership with Master Win to add several more strains to our Amster-Can branded offerings.” Cherry explained that Advantis had previously tested several strains from different partners before choosing Natural Elements’ OG Kush, Gorilla Glue, and Blue Dream as the highest quality options to put the Amster-Can name on. This new partnership with Master Win provides Advantis a new partner with a significant research background to bring new possibilities to the table. “We obviously only want the highest quality cannabis associated with our brand name,” Cherry explained. “Master Win will not only provide us the finest quality flowers that we will brand with Amster-Can, he will also be working with us to further develop and distribute our branded extracts, sublinguals, and other Amster-Can branded offerings.” To this point, Amster- Can has relied on Southern California mutual benefit company, Natural Elements, to grow and develop Amster- Can products. This new partnership is an effort to expand Advantis’ reach in addition to expanding its partnership with Natural Elements, itself. “This new partnership will also result in expanding our partnership with Natural Elements, as we continue to build our existing product lineup with them.”
As the company continues to expand its offerings, it is actively working on improving its ability to market itself. “We are gaining traction on our own and getting close to adding some ‘octane’ to our marketing abilities,” Cherry announced. Advantis is having UFC legend, Kimo, test certain pain-relieving products to ascertain which ones he wants to personally endorse and put his stamp of approval on. “We are extremely excited to get Kimo’s opinion of the Amster-Can products he finds most effective. Kimo has much respect and quite a following that will value his endorsement.” Cherry added that the company continues to expand its digital presence and is still working on finalizing the agreement with Herb N’ Works. “We are firing on all cylinders,” Cherry reflected. “We have come a long way since we began this journey with Amster-Can. Our partnership with Natural Elements helped establish our footprint, Master Win will help us expand that footprint, and all our clients and partners continue growing together. I love having Kimo as part of our family advocating for what he truly feels is the highest quality brand in the marketplace. Advantis,” Cherry concluded.
Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.
Links to Advantis pictures and websites can be found on Facebook and Instagram pages, and at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com.
About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.